Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Good Biomarker Sciences (GBS) is a specialized contract research organization (CRO) based in the Leiden Bio Science Park, Netherlands. Founded in 2007 as a spin-off from TNO, the company provides expert services in biomarker development, validation, and clinical sample analysis. GBS is particularly recognized for its deep expertise in hemostasis, thrombosis, and inflammation, supporting drug development from preclinical stages through Phase IV clinical trials. The company utilizes advanced technologies such as flow cytometry, functional cell-based assays, and specialized coagulation testing to provide high-quality data for pharmaceutical and biotech clients. By offering tailored analytical solutions and fit-for-purpose assay validation, GBS helps researchers understand drug mechanisms and evaluate clinical efficacy and safety.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Good Biomarker Sciences.